José Ignacio Martín-Subero
ICREA-IDIBAPSResearch group
- Biomedical epigenomics Group leader (R4)
About me
Dr. Martin-Subero graduated from the University of Navarra (Spain) with a degree in Biochemistry. In 2001, he completed a PhD with honours as a joined effort between the University of Navarra and the Christian-Albrechts University of Kiel (Germany). He continued his postdoctoral training at the Christian-Albrechts University. Upon returning to Spain in 2009, he started to coordinate a research group on epigenomics at the University of Barcelona. In 2016, he was appointed leader of the Biomedical Epigenomics group at the IDIBAPS research institute in Barcelona, and in 2018 he was awarded with an ICREA Research Professorship. He has published over 200 peer-reviewed articles.
Featured publications
-
Insight into genetic predisposition to chronic lymphocytic leukemia from integrative epigenomics
Authors:Reference: Nature Communications 2019. -
Insight into origins, mechanisms & utility of DNA methylation in B cell malignancies.
Authors:Reference: Blood 2018. -
Charting the dynamic epigenome during B-cell development
Authors:Reference: Seminars In Cancer Biology 2018. -
The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia
Authors:Reference: Nature Medicine 2018. -
Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage
Authors:Reference: Cancer Cell 2016. -
Whole-genome fingerprint of the DNA methylome during human B cell differentiation
Authors:Reference: Nature Genetics 2015. -
Whole-epigenome analysis in multiple myeloma reveals DNA hypermethylation of B cell-specific enhancers
Authors:Reference: Genome Research 2015. -
A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact
Authors:Reference: Leukemia 2015. -
Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
Authors:Reference: Nature Genetics 2012.
Featured Projects
-
Deciphering the pathogenetic and clinical role of aberrant DNA methylation of enhancer elements in chronic lymphocytic leukemia
Principal investigator: José Ignacio Martín SuberoFunder: World Cancer Research Fund InternationalCode: 16-1285Duration: 01/07/2016 - 30/06/2019 -
Functional and clinical impact of enhancer DNA methylation in mantle cell lymphoma
Principal investigator: José Ignacio Martín SuberoFunder: European Hematology Association (EHA)Code: INT_EHA_Fellow13septDuration: 16/11/2014 - 15/11/2017 -
Análisi del (hidroxi)metiloma sencer de I'ADN i del transcriptoma en el Mieloma Múltiple
Principal investigator: José Ignacio Martín SuberoFunder: Fundació La Marató de TV3Code: 20132130Duration: 01/01/2014 - 01/01/2017 -
A BLUEPRINT of Haematopoietic Epigenomes
Principal investigator: José Ignacio Martín SuberoFunder: European CommissionCode: HEALTH-F5-2011-282510Duration: 01/10/2011 - 30/09/2017 -
Caracterización epigenómica de las neoplasias hematológicas
Principal investigator: José Ignacio Martín SuberoFunder: Ministerio de Educación y Ciencia (MEC)Code: SAF2009-08663Duration: 10/11/2010 - 31/12/2012